1.
Well-Differentiated Gastric Tumors/Carcinomas
by Ruszniewski, Philippe
Neuroendocrinology, 2007-02, Vol.84 (3), p.158-164
2.
Gastric cancer
by Van Cutsem, Eric, Prof
The Lancet (British edition), 2016, Vol.388 (10060), p.2654-2664
3.
ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas
by Garcia-Carbonero, R
Neuroendocrinology, 2016-04, Vol.103 (2), p.186-194
4.
Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers
by van der Post, Rachel S
Journal of Medical Genetics, 2015-06, Vol.52 (6), p.361-374
5.
Occupational Exposures and Risk of Esophageal and Gastric Cardia Cancers among Male Swedish Construction Workers
by Jansson, Catarina
Cancer causes & control, 2005-08-01, Vol.16 (6), p.755-764
6.
Guidelines for the management of oesophageal and gastric cancer
by Allum, William H
Gut, 2011-11, Vol.60 (11), p.1449-2
7.
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and...
by Klöppel, Günter
Neuroendocrinology, 2009-08, Vol.90 (2), p.162-166
8.
ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
by Delle Fave, G
Neuroendocrinology, 2016-04, Vol.103 (2), p.119-124
9.
Management of gastric cancer in Asia: resource-stratified guidelines
by Shen, Lin, Prof
The lancet oncology, 2013, Vol.14 (12), p.e535-e547
10.
Gastric cancer
by Hartgrink, Henk H, MD
The Lancet (British edition), 2009, Vol.374 (9688), p.477-490
11.
The challenge of screening for early gastric cancer in China
by Zong, Liang
The Lancet (British edition), 2016, Vol.388 (10060), p.2606-2606
12.
Risk stratification of patients diagnosed with gastrointestinal stromal tumor
by Joensuu, Heikki, MD, PhD
Human pathology, 2008, Vol.39 (10), p.1411-1419
13.
ENETS Consensus Guidelines for the Management of Patients with Gastroduodenal Neoplasms
by Delle Fave, Gianfranco
Neuroendocrinology, 2012-02, Vol.95 (2), p.74-87
14.
Plasma long noncoding RNA protected by exosomes as a potential stable biomarker for gastric cancer
by Li, Qier
Tumor biology, 2014-11-13, Vol.36 (3), p.2007-2012
15.
Screening for gastric cancer in Asia: current evidence and practice
by Leung, Wai K, Dr
The lancet oncology, 2008, Vol.9 (3), p.279-287
16.
The concept of oligometastatic disease in gastric cancer: reality or fiction?
by Kassar, Serge
Future oncology (London, England), 2021-10-01, Vol.18 (2), p.135-138
17.
Screening of gastric cancer in Asia
by Sugano, Kentaro, MD, Professor Emeritus
Baillière's best practice & research. Clinical gastroenterology, 2015, Vol.29 (6), p.895-905
18.
Molecular imaging with 68Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours
by Kaemmerer, Daniel
European journal of nuclear medicine and molecular imaging, 2011-05-31, Vol.38 (9), p.1659-1668
19.
Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research
by Fitzgerald, Rebecca C
Journal of medical genetics, 2010-07, Vol.47 (7), p.436-444
20.
JNETS clinical practice guidelines for gastroenteropancreatic neuroendocrine neoplasms: diagnosis, treatment, and follow-up: a synopsis
by Ito, Tetsuhide
Journal of gastroenterology, 2021-09-29, Vol.56 (11), p.1033-1044
